My conjecturing leads one to believe that Lee's Pharmaceutical will announce a clinical trial sometime in the near future and this could be the event that leads to other news such as patent announcements and changes in patent language.
I do not Lee's will start a trial in China for Dry Eye, or any other TB 4 thing. Because if RGRX goes bankrupt, so do all RGRX contracts. All rights & patents of TB 4 go back to the NIH. So why would Lee's spend $$ to do a trial...and maybe see some good things possibly..only to then see RGRX go bankrupt and all contracts are probably then null and void. RGRX no longer exists.Then the NIH get's TB 4 back. What position does that leave Lee's in? I would think the contract is good only as long as RGRX is in business. It's why I have been saying that the next 3 days are critical for RGRX. We have to see the 10-K/10-Q (later) and we have to see if Mgmt, BOD and ST are willing to put another $300,000 band aid package together. If they are not willing to, RGRX is dead and goes to zero. But if they think there is some good news possibly soon, they will do another $300k. But I do not think Lee's will do any trial w/ TB 4 until they are certain that RGRX will exist later on.